Cui featured speaker for Society of Biomaterials talk on nano

Join the Society for Biomaterials for their last meeting of the semester today, December 4 at 5 p.m. in Maryland Hall room 109 on the Homewood campus of Johns Hopkins University. Honggang Cui, assistant professor of chemical and biomolecular engineering, will present “How Nano Impacts Medicine.” Refreshments will be served. Cui is an affiliated faculty member of Johns Hopkins Institute for NanoBioTechnology.

Here is an abstract for Dr. Cui’s talk:

honggangcui2-7-13-web

Honggang Cui

From the dawn of civilization, humans have recognized the therapeutic effect of some natural herbs, and the use of plants as therapeutic agents is a long-standing practice throughout the human history. However, the major advance in medicine did not start until the mid-19th century when the active compounds could be actually isolated, purified and identified. The identification of the active compound and its pharmacophore allows not only for the administration of drugs with a known dose, but more importantly for the synthesis of modified drugs with improved efficacy.

Nowadays, modern pharmacology has become part of our daily living, greatly improving the quality of life and transforming the way we live. However, there are still many incurable diseases, such as cancer, that medicine has yet to provide a solution. The emergence of nanotechnology as a field in 1980s has impacted many scientific disciplines including medicine. In particular, nanotechnology-based medicine has entered clinical use over the past two decades.

Can nano help provide a revolutionary solution to cancer? And how could the uses of nano improve the current clinical practice in cancer treatments? This lecture will provide a brief overview of the impact that nanotechnology could have on medicine.

 

 

 

Leave a Comment

*